{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:17:23Z","timestamp":1774678643405,"version":"3.50.1"},"reference-count":26,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,3,28]]},"DOI":"10.1248\/bpb.b26-00018","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T22:08:50Z","timestamp":1774649330000},"page":"572-577","source":"Crossref","is-referenced-by-count":0,"title":["Establishment of Irinotecan-Induced Oral Mucositis Hamster Model and Evaluation of Therapeutic Agents"],"prefix":"10.1248","volume":"49","author":[{"given":"Shinichi","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakura","family":"Toyooka","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaede","family":"Utsunomiya","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiro","family":"Kurokawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakagami","sequence":"additional","affiliation":[{"name":"R&amp;D Division, Daiichi Sankyo Co., Ltd., 1\u20132\u201358 Hiromachi, Shinagawa-ku, Tokyo 140\u20138710, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University, 4\u20132 Bunkyo-cho, Matsuyama, Ehime 790\u20138578, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. <i>Oral Oncol.<\/i>, <b>34<\/b>, 39\u201343 (1998).","DOI":"10.1016\/S1368-8375(97)00053-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. <i>Cancer<\/i>, <b>100<\/b> (Supplement), 1995\u20132025 (2004).","DOI":"10.1002\/cncr.20162"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sonis ST, Tracey C, Shklar G, Jenson J, Florine D. An animal model for mucositis induced by cancer chemotherapy. <i>Oral Surg. Oral Med. Oral Pathol.<\/i>, <b>69<\/b>, 437\u2013443 (1990).","DOI":"10.1016\/0030-4220(90)90376-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Watanabe S, Suemaru K, Yamaguchi T, Hidaka N, Sakanaka M, Araki H. Effect of oral mucosal adhesive films containing ginsenoside Rb1 on 5-fluorouracil-induced oral mucositis in hamsters. <i>Eur. J. Pharmacol.<\/i>, <b>616<\/b>, 281\u2013286 (2009).","DOI":"10.1016\/j.ejphar.2009.06.028"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Leit\u00e3o RF, Ribeiro RA, Bellaguarda EA, Macedo FD, Silva LR, Ori\u00e1 RB, Vale ML, Cunha FQ, Brito GA. Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster. <i>Cancer Chemother. Pharmacol.<\/i>, <b>59<\/b>, 603\u2013612 (2007).","DOI":"10.1007\/s00280-006-0301-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Jansman FG, Sleijfer DT, de Graaf JC, Coenen JL, Brouwers JR. Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer. <i>Drug Saf.<\/i>, <b>24<\/b>, 353\u2013367 (2001).","DOI":"10.2165\/00002018-200124050-00002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kciuk M, Marciniak B, Kontek R. Irinotecan-still an important player in cancer chemotherapy: a comprehensive overview. <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b>, 4919 (2020).","DOI":"10.3390\/ijms21144919"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Murphy CK, Fey EG, Watkins BA, Wong V, Rothstein D, Sonis ST. Efficacy of superoxide dismutase mimetic M40403 in attenuating radiation-induced oral mucositis in hamsters. <i>Clin. Cancer Res.<\/i>, <b>14<\/b>, 4292\u20134297 (2008).","DOI":"10.1158\/1078-0432.CCR-07-4669"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Watanabe S, Suemaru K, Nakanishi M, Nakajima N, Tanaka M, Tanaka A, Araki H. Assessment of the hamster cheek pouch as a model for radiation-induced oral mucositis, and evaluation of the protective effects of keratinocyte growth factor using this model. <i>Int. J. Radiat. Biol.<\/i>, <b>90<\/b>, 884\u2013891 (2014).","DOI":"10.3109\/09553002.2014.922716"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Al-Azri AR, Gibson RJ, Bowen JM, Stringer AM, Keefe DM, Logan RM. Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis. <i>J. Oral Pathol. Med.<\/i>, <b>44<\/b>, 459\u2013467 (2015).","DOI":"10.1111\/jop.12255"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Takahashi T, Nagai K, Kotake K. Efficacy of hangeshashinto in the prevention of chemotherapy-induced diarrhea: a systematic review and meta-analysis. <i>Cureus<\/i>, <b>15<\/b>, e50377 (2023).","DOI":"10.7759\/cureus.50377"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Aoyama T, Tamagawa H. The clinical effect of Kampo medicine in multimodal treatment for gastrointestinal cancer in Japan. <i>J. Cancer<\/i>, <b>11<\/b>, 5390\u20135394 (2020).","DOI":"10.7150\/jca.46748"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kono T, Satomi M, Chisato N, Ebisawa Y, Suno M, Asama T, Karasaki H, Matsubara K, Furukawa H. Topical application of hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis. <i>World J. Oncol.<\/i>, <b>1<\/b>, 232\u2013235 (2010).","DOI":"10.4021\/wjon263w"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Yoshimatsu M, Kawashita Y, Soutome S, Murata M, Sawayama Y, Kurogi T, Nakao N, Miyazaki Y, Umeda M, Ukai T. Hangeshashinto for prevention of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized phase II study. <i>Support. Care Cancer<\/i>, <b>31<\/b>, 707 (2023).","DOI":"10.1007\/s00520-023-08175-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kawashita Y, Umeda M, Murata M, Yoshimatsu M, Shiraishi C, Omori A, Yamazaki T, Nishi H, Soutome S, Ukai T, Toya R, Kumai Y. Effectiveness of Hangeshashinto in delaying grade 2 radiotherapy-induced mucositis development in patients with hypopharyngeal or laryngeal cancer: preliminary finding of a randomized clinical trial. <i>Medicine<\/i>, <b>104<\/b>, e42870 (2025).","DOI":"10.1097\/MD.0000000000042870"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Rugo HS, Seneviratne L, Beck JT, Glaspy JA, Peguero JA, Pluard TJ, Dhillon N, Hwang LC, Nangia C, Mayer IA, Meiller TF, Chambers MS, Sweetman RW, Sabo JR, Litton JK. Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial. <i>Lancet Oncol.<\/i>, <b>18<\/b>, 654\u2013662 (2017).","DOI":"10.1016\/S1470-2045(17)30109-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kuba S, Maeda S, Shibata K, Soutome S, Yamanouchi K, Matsumoto M, Tanaka A, Morita M, Hatachi T, Otsubo R, Yano H, Kawashita Y, Sato S, Taniguchi H, Kanetaka K, Umeda M, Nagayasu T, Eguchi S. Efficacy and safety of a dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in women with breast cancer: a multicentre, open-label, randomised PHASE 2 study. <i>J. Evid. Based Dent. Pract.<\/i>, <b>23<\/b>, 101896 (2023).","DOI":"10.1016\/j.jebdp.2023.101896"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Watanabe S, Suemaru K, Takechi K, Kaji H, Imai K, Araki H. Oral mucosal adhesive films containing royal jelly accelerate recovery from 5-Fluorouracil-induced oral mucositis. <i>J. Pharmacol. Sci.<\/i>, <b>121<\/b>, 110\u2013118 (2013).","DOI":"10.1254\/jphs.12181FP"},{"key":"19","unstructured":"19) Katayama S, Nishizawa K, Hirano M, Yamamura S, Momose Y. Effect of polaprezinc on healing of acetic acid-induced stomatitis in hamsters. <i>J. Pharm. Pharm. Sci.<\/i>, <b>3<\/b>, 114\u2013117 (2000)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Rowland TL, McHugh SM, Deighton J, Ewan PW, Dearman RJ, Kimber I. Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B. <i>Int. Immunopharmacol.<\/i>, <b>1<\/b>, 49\u201361 (2001).","DOI":"10.1016\/S0162-3109(00)00265-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Stepanenko AA, Sosnovtseva AO, Valikhov MP, Chernysheva AA, Abramova OV, Naumenko VA, Chekhonin VP. The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy. <i>Front. Immunol.<\/i>, <b>15<\/b>, 1326757 (2024).","DOI":"10.3389\/fimmu.2024.1326757"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Beer HD, F\u00e4ssler R, Werner S. Glucocorticoid-regulated gene expression during cutaneous wound repair. <i>Vitam. Horm.<\/i>, <b>59<\/b>, 217\u2013239 (2000).","DOI":"10.1016\/S0083-6729(00)59008-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Miyano K, Eto M, Hitomi S, Matsumoto T, Hasegawa S, Hirano A, Nagabuchi K, Asai N, Uzu M, Nonaka M, Omiya Y, Kaneko A, Ono K, Fujii H, Higami Y, Kono T, Uezono Y. The Japanese herbal medicine hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis. <i>Sci. Rep.<\/i>, <b>10<\/b>, 625 (2020).","DOI":"10.1038\/s41598-020-76581-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ikarashi N, Kon R, Sakai H, Hosoe T. Role of the gut microbiota in the pharmacological effects of traditional Kampo medicine and natural products. <i>J. Nat. Med.<\/i>, <b>79<\/b>, 1447\u20131454 (2025).","DOI":"10.1007\/s11418-025-01959-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Arifa RD, Madeira MF, de Paula TP, Lima RL, Tavares LD, Menezes-Garcia Z, Fagundes CT, Rachid MA, Ryffel B, Zamboni DS, Teixeira MM, Souza DG. Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1\u03b2 and IL-18 in mice. <i>Am. J. Pathol.<\/i>, <b>184<\/b>, 2023\u20132034 (2014).","DOI":"10.1016\/j.ajpath.2014.03.012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Matsumoto C, Sekine-Suzuki E, Nyui M, Ueno M, Nakanishi I, Omiya Y, Fukutake M, Kase Y, Matsumoto K. Analysis of the antioxidative function of the radioprotective Japanese traditional (Kampo) medicine, hangeshashinto, in an aqueous phase. <i>J. Radiat. Res.<\/i>, <b>56<\/b>, 669\u2013677 (2015).","DOI":"10.1093\/jrr\/rrv023"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b26-00018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:22:34Z","timestamp":1774668154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b26-00018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00018","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"article-number":"b26-00018"}}